Valuation: Gujarat Themis Biosyn Limited

Capitalization 3.07TCr 36Cr 31Cr 29Cr 26Cr 49Cr 55Cr 341.01Cr 130.23Cr 1.43TCr 134.15Cr 131.4Cr 5.24TCr P/E ratio 2023
17.2x
P/E ratio 2024 48.7x
Enterprise value 3.06TCr 36Cr 30Cr 28Cr 26Cr 49Cr 54Cr 339.69Cr 129.73Cr 1.43TCr 133.63Cr 130.89Cr 5.22TCr EV / Sales 2023
6.64x
EV / Sales 2024 16.9x
Free-Float
28.05%
Yield 2023
0.79%
Yield 2024 0.25%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.14%
1 week-0.70%
Current month-0.63%
1 month+0.57%
3 months+40.66%
6 months+2.95%
Current year+13.08%
More quotes
1 week 340
Extreme 340
364.65
1 month 308.8
Extreme 308.8
364.65
Current year 192.35
Extreme 192.35
364.65
1 year 192.35
Extreme 192.35
390
3 years 56.15
Extreme 56.1467
390
5 years 22
Extreme 22
390
10 years 3.75
Extreme 3.7533
390
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 01/07/2025
Director TitleAgeSince
Chairman 76 25/05/1992
Director/Board Member - 28/05/2015
Director/Board Member - 01/05/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.14%-0.70%+1.80%+503.35% 44Cr
-0.41%-0.89%+4.86%+93.83% 4.67TCr
+0.77%-2.42%-5.64%+33.51% 2.41TCr
+0.97%+4.95%+31.91% - 2.4TCr
-0.93%-1.32%-2.27%+57.98% 1.41TCr
-0.56%-2.26%-16.52%+165.87% 1.15TCr
-0.11%-5.55%+69.63%+69.44% 703.22Cr
+0.26%+1.03%+38.52%+100.00% 699.97Cr
-.--%+0.14% - - 678.76Cr
+4.68%+7.57%+40.10%+391.35% 598.74Cr
Average +0.36%-0.48%+18.04%+176.92% 1.48TCr
Weighted average by Cap. +0.22%-0.39%+11.61%+99.87%
See all sector performances

Financials

2023 2024
Net sales 148.97Cr 1.74Cr 1.49Cr 1.39Cr 1.28Cr 2.38Cr 2.65Cr 17Cr 6.33Cr 70Cr 6.52Cr 6.38Cr 254.42Cr 169.82Cr 1.98Cr 1.69Cr 1.58Cr 1.46Cr 2.71Cr 3.02Cr 19Cr 7.21Cr 79Cr 7.43Cr 7.27Cr 290.02Cr
Net income 58Cr 67.6L 57.84L 53.9L 49.84L 92.52L 1.03Cr 6.44Cr 2.46Cr 27Cr 2.54Cr 2.48Cr 99Cr 59Cr 69L 59.03L 55.01L 50.87L 94.42L 1.05Cr 6.58Cr 2.51Cr 28Cr 2.59Cr 2.53Cr 101.04Cr
Net Debt -8.48Cr -10L -8L -8L -7L -13.54L -15.07L -94.32L -36.02L -3.96Cr -37.1L -36.34L -14Cr -12Cr -13.78L -11.79L -10.98L -10.16L -18.86L -20.99L -1.31Cr -50.16L -5.52Cr -51.67L -50.61L -20Cr
More financial data * Estimated data
Logo Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy).
Employees
159
More about the company
Date Price Change Volume
10/25/10 345.40 -1.14% 7,088
09/25/09 349.40 +0.50% 29,480
08/25/08 347.65 +0.45% 16,215
07/25/07 346.10 -1.24% 10,630
04/25/04 350.45 +2.68% 25,334

Delayed Quote Bombay S.E., July 10, 2025 at 03:30 pm IST

More quotes
  1. Stock Market
  2. Equities
  3. GUJTHEM Stock